Stocklytics Platform
Asset logo for symbol TMDX
TransMedics Group
TMDX72
$123.43arrow_drop_up0.10%$0.13
Asset logo for symbol TMDX
TMDX72

$123.43

arrow_drop_up0.10%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

TransMedics Group (TMDX) Stocklytics Forecast

According to the latest stock price predictions, TransMedics Group Inc (TMDX) is expected to show positive growth in the coming years. Analysts forecast that the TMDX stock will continue its upward trajectory and reach new heights in 2023. With the advancements in artificial intelligence (AI) and machine learning (ML) technologies, the accuracy of stock price predictions has improved significantly. Based on AI algorithms, TMDX is predicted to achieve substantial gains in the near future.
The average price target for TransMedics Group Inc (TMDX) in 2023, as estimated by analysts, is quite optimistic. Experts believe that TMDX stock has the potential to reach impressive levels by that time. Furthermore, analysts' ratings for TMDX have been positive, indicating that the stock is considered a good investment opportunity. With a strong focus on innovation and the development of groundbreaking medical instruments, TransMedics Group Inc is well-positioned for growth in the coming years.
add TransMedics Group to watchlist

Keep an eye on TransMedics Group

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for TransMedics Group (TMDX) stock?

Analysts have set a target price of $60.84 for TransMedics Group (TMDX), based on forecasts from 25 analysts. The predicted price range extends from a high of $110 to a low of $25. This represents a potential increase of up to -10.88% and a decrease of -79.75% from the current price of $123.44. These forecasts are as of 2020 Nov 06.
help

What are the analyst ratings for TransMedics Group (TMDX) stock?

The analyst ratings for TransMedics Group (TMDX) are distributed as follows: 9 analysts recommend buying, 3 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 12 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering TransMedics Group .
help

What is the AI price prediction for TransMedics Group (TMDX) stock?

At present, there is no AI or machine-learning-based price prediction available for TransMedics Group (TMDX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level